Physician profile
Javier Miller
NPI 1497977029
$10,992.85
in general payments reported to CMS, 2019-2025
63 companies · $1,932 in 2025
The $1,932 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,082 · 2020: $951 · 2021: $1,613 · 2022: $1,517 · 2023: $2,308 · 2024: $1,590 · 2025: $1,932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,775 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,775.46 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,640.46 | 2019-2024 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $1,622.45 | 2021-2025 | Prolaris, Myrisk |
| Coloplast Corp | $1,178.23 | 2019-2025 | Speedicath |
| Axonics, INC. | $841.60 | 2020-2024 | Axonics |
| Boston Scientific Corporation | $485.24 | 2019-2025 | Axonics, Ams 800 Artificial Urinary Sphincter, Moses |
| Sumitomo Pharma America, INC. | $398.29 | 2023-2025 | Orgovyx, Gemtesa |
| Intuitive Surgical, INC. | $355.66 | 2022-2023 | Da Vinci Surgical System |
| Endo USA, INC. | $343.01 | 2024-2025 | Xiaflex, Aveed |
| Astellas Pharma US INC | $307.87 | 2019-2023 | Veozah, Myrbetriq |
| Urogen Pharma, INC. | $290.01 | 2021-2025 | Jelmyto |
| Janssen Biotech, INC. | $275.81 | 2019-2025 | Erleada |
| Blue Earth Diagnostics | $252.76 | 2023-2025 | Posluma |
| Myovant Sciences INC. | $236.55 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $201.23 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $175.74 | 2022-2024 |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.